+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bacteriophage Market - Global Forecast to 2030- Product Image
Bacteriophage Market - Global Forecast to 2030- Product Image
New

Bacteriophage Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083448
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bacteriophage Market grew from USD 50.15 million in 2024 to USD 52.83 million in 2025. It is expected to continue growing at a CAGR of 5.30%, reaching USD 68.38 million by 2030.

Bacteriophages, viruses that specifically infect bacteria, are garnering unprecedented attention as a potent alternative in the fight against antimicrobial resistance. Since their discovery in the early 20th century, phages have undergone a renaissance driven by escalating drug-resistant infections and a global imperative for novel biocontrol strategies. Today’s market landscape is shaped by advances in genomic screening, formulation science, and regulatory frameworks that accommodate precision biologics. As stakeholders-from researchers to biotechnology companies-seek to harness phage therapy’s specificity and self-amplifying properties, the industry is poised for a transformative growth phase. This introduction outlines the core drivers energizing the bacteriophage sector and sets the stage for a deeper examination of emerging shifts, tariff impacts, segmentation nuances, regional distinctions, leading players, and strategic recommendations. Through this executive summary, decision-makers will gain a panoramic view of current trends, technological breakthroughs, and actionable insights essential for navigating the evolving bacteriophage ecosystem.

Transformative Shifts Reshaping the Bacteriophage Sector

The bacteriophage landscape is undergoing a series of transformative shifts that are redefining research priorities and market opportunities. Precision phage therapy has evolved from experimental case studies into scalable platforms, powered by synthetic biology tools that engineer phages for enhanced host specificity and payload delivery. Regulatory agencies across key markets have begun to issue guidance on compassionate use and adaptive clinical trial designs, signaling greater acceptance of phage therapeutics. Meanwhile, advances in artificial intelligence and machine learning are accelerating phage discovery pipelines, optimizing host-range predictions and formulation stability. Cross-sector collaborations between academic institutions, pharmaceutical giants, and agricultural firms are bridging the gap between early-stage research and commercial deployment. Furthermore, the growing interest in phage cocktails for multi-targeted interventions underscores a shift toward combination therapies that mitigate bacterial resistance. As investment capital flows into specialized biotechnology startups, the stage is set for next-generation phage products to move from proof-of-concept to mainstream adoption.

Assessing the Impact of 2025 US Tariffs on Phage Supply Chains

In 2025, newly implemented United States tariffs have exerted a notable influence on global bacteriophage supply chains and manufacturing economics. Duties on imported laboratory reagents and bioprocessing consumables have elevated production costs for phage purification and formulation, prompting companies to reassess procurement strategies. To mitigate these headwinds, several manufacturers have accelerated domestic sourcing of filtration membranes and chromatographic resins, fostering localized supply networks. Conversely, higher input expenses have spurred exploration of alternative purification methods and process intensification techniques that reduce reagent consumption. On the demand side, increased costs have translated into higher per-dose pricing for phage therapies, pushing payers and healthcare systems to scrutinize value demonstrations more rigorously. At the same time, tariff-driven incentives for onshore manufacturing are strengthening regional production hubs, which may ultimately enhance supply resilience. Collectively, these dynamics underscore the importance of agility in procurement, process innovation, and value-based pricing strategies in a tariff-impacted environment.

Key Segmentation Insights Across Phage Modalities and Use Cases

A nuanced segmentation framework reveals distinct avenues for market penetration. By type, the domain encompasses lysogenic phages-studied across filamentous and temperate variants-and strictly lytic phages designed for targeted bacterial eradication. In application, opportunities span agricultural uses with a focus on animal health, aquaculture interventions targeting fish pathogen control, food and beverage safety protocols, and therapeutic applications addressing infectious diseases and oncology. End-user segmentation highlights biotechnology firms, pharmaceutical companies, research institutes, and self-medication channels as primary adopters, each with unique R&D and commercial imperatives. Product-based analysis centers on bacteriophage preparations delivered via injectable formulations, oral suspensions, and topical solutions. Source considerations emphasize natural phage reservoirs, while route-of-administration choices among injectable, oral, and topical formats reflect evolving clinical and non-clinical use cases. Finally, targeting strategies differentiate between gram-negative infections-such as those caused by Enterobacteriaceae and Pseudomonads-and gram-positive infections, underscoring the need for tailored phage cocktails to address specific bacterial taxonomies.

Regional Dynamics Shaping Phage Research and Commercialization

Regional insights illuminate how geographic factors shape phage research, commercialization, and adoption. In the Americas, robust funding for antimicrobial resistance initiatives and a well-established biotech infrastructure drive early adoption of phage therapies, with notable activity in academic-industry partnerships and clinical trials. Europe, Middle East & Africa benefits from harmonized regulatory frameworks under centralized agencies, facilitating multicenter studies and cross-border collaboration; emerging economies in this cluster are increasingly investing in phage research for agricultural biosecurity. The Asia-Pacific region exhibits strong government support for biopharmaceutical innovation, particularly in nations emphasizing domestic biomanufacturing capacity, and sees growing interest in phage applications for aquaculture and food safety to support rapidly expanding protein markets. Each zone presents distinct regulatory, investment, and demand profiles that demand tailored strategies for product development, market entry, and stakeholder engagement.

Leading Companies Driving Innovation in Phage Therapeutics

Leadership within the bacteriophage arena is defined by a blend of innovative platforms, robust pipelines, and strategic partnerships. Adaptive Phage Therapeutics has pioneered personalized phage cocktails, leveraging rapid matching algorithms to target patient-specific bacterial strains. AmpliPhi Biosciences Corporation advances its modular manufacturing capacity and platform technologies to accelerate late-stage clinical assets. Armata Pharmaceuticals Inc. continues to refine its lead candidates for multi-drug-resistant pathogens. ContraFect Corporation and CYTOO S.A. explore novel delivery systems and high-throughput screening methods, while Eligo Bioscience employs CRISPR-enhanced phages for precision editing of bacterial genomes. EnBiotix Inc. focuses on proprietary formulation approaches to enhance in vivo stability. Fixed-Phage Limited and Intralytix Inc. maintain diversified portfolios across therapeutics and food safety, and iNtRON Biotechnology invests in scalable fermentation processes. Locus Biosciences Inc. advances CRISPR-enabled phage therapeutics, complemented by Micreos BV’s naturally derived endolysin solutions. Optipharm Co. Ltd. emphasizes hybrid small-molecule/phage formulations, while Phage International Inc. and Phagelux Inc. extend global manufacturing networks. Phagomed Biopharma GmbH, Pherecydes Pharma, Phico Therapeutics Ltd., Sexton Biotechnologies, and TechnoPhage SA each carve distinct niches-ranging from veterinary applications to advanced clinical-stage programs-underscoring the varied strategic positions across the competitive landscape.

Actionable Recommendations for Stakeholders in the Phage Ecosystem

To capitalize on emerging opportunities and mitigate sector-specific challenges, industry leaders should adopt a multifaceted approach. First, invest in collaborative research platforms that integrate artificial intelligence-driven discovery with high-throughput screening to accelerate candidate identification and host-range validation. Second, engage proactively with regulatory authorities to shape adaptive clinical trial frameworks and secure early guidance on quality standards, especially for phage cocktails and genetically engineered constructs. Third, diversify supply chains by establishing regional manufacturing alliances and exploring continuous processing technologies that reduce dependence on imported consumables. Fourth, pursue strategic partnerships across agriculture, aquaculture, food safety, and healthcare sectors to broaden application portfolios and demonstrate cross-sector efficacy. Fifth, focus on combination therapy development-integrating phages with antibiotics, antivirulence agents, or probiotics-to enhance therapeutic robustness and extend patent lifecycles. Sixth, implement targeted education programs for clinicians and key opinion leaders to build confidence in phage modalities. Finally, tailor go-to-market strategies to regional regulatory landscapes, leveraging local distribution networks and public-private partnerships to accelerate adoption.

Conclusion: Navigating the Next Phase of Phage Innovation

The bacteriophage sector stands at a critical inflection point, characterized by surging scientific momentum and evolving market forces. The convergence of advanced biomanufacturing, regulatory openness, and digital discovery tools has unlocked new potential for phage-based interventions across therapeutic, agricultural, and food safety domains. Yet, challenges remain-from supply chain vulnerabilities under tariff pressures to the need for robust clinical validation and stakeholder education. By harnessing the insights outlined here-spanning segmentation dynamics, regional nuances, and competitive landscapes-organizations can craft strategies that align with market realities and future-proof their investments. As the industry advances, those who adopt a proactive, collaborative approach will be best positioned to translate phage promise into widespread, sustainable impact.

Market Segmentation & Coverage

This research report categorizes the Bacteriophage Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Lysogenic Phages
    • Filamentous Phages
    • Temperate Phages
  • Lytic Phages
  • Agricultural
    • Animal Health
  • Aquaculture
    • Fish Pathogen Control
  • Food & Beverage
    • Food Safety
  • Therapeutic Applications
    • Infectious Diseases
    • Oncology
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Research Institutes
  • Self-Medication
  • Bacteriophage Preparation
    • Injectable Formulations
    • Oral Suspensions
    • Topical Solutions
  • Natural
  • Injectable
  • Oral
  • Topical
  • Gram-negative Infections
    • Enterobacteriaceae
    • Pseudomonads
  • Gram-positive Infections

This research report categorizes the Bacteriophage Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bacteriophage Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Adaptive Phage Therapeutics
  • AmpliPhi Biosciences Corporation
  • Armata Pharmaceuticals Inc.
  • ContraFect Corporation
  • CYTOO S.A.
  • Eligo Bioscience
  • EnBiotix Inc.
  • Fixed-Phage Limited
  • Intralytix Inc.
  • iNtRON Biotechnology
  • Locus Biosciences Inc.
  • Micreos BV
  • Optipharm Co. Ltd.
  • Phage International Inc.
  • Phagelux Inc.
  • Phagomed Biopharma GmbH
  • Pherecydes Pharma
  • Phico Therapeutics Ltd.
  • Sexton Biotechnologies
  • TechnoPhage SA

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bacteriophage Market, by Type
8.1. Introduction
8.2. Lysogenic Phages
8.2.1. Filamentous Phages
8.2.2. Temperate Phages
8.3. Lytic Phages
9. Bacteriophage Market, by Application
9.1. Introduction
9.2. Agricultural
9.2.1. Animal Health
9.3. Aquaculture
9.3.1. Fish Pathogen Control
9.4. Food & Beverage
9.4.1. Food Safety
9.5. Therapeutic Applications
9.5.1. Infectious Diseases
9.5.2. Oncology
10. Bacteriophage Market, by End-User
10.1. Introduction
10.2. Biotechnology Companies
10.3. Pharmaceutical Companies
10.4. Research Institutes
10.5. Self-Medication
11. Bacteriophage Market, by Product
11.1. Introduction
11.2. Bacteriophage Preparation
11.2.1. Injectable Formulations
11.2.2. Oral Suspensions
11.2.3. Topical Solutions
12. Bacteriophage Market, by Source
12.1. Introduction
12.2. Natural
13. Bacteriophage Market, by Route Of Administration
13.1. Introduction
13.2. Injectable
13.3. Oral
13.4. Topical
14. Bacteriophage Market, by Target Bacteria
14.1. Introduction
14.2. Gram-negative Infections
14.2.1. Enterobacteriaceae
14.2.2. Pseudomonads
14.3. Gram-positive Infections
15. Americas Bacteriophage Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Bacteriophage Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Bacteriophage Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Adaptive Phage Therapeutics
18.3.2. AmpliPhi Biosciences Corporation
18.3.3. Armata Pharmaceuticals Inc.
18.3.4. ContraFect Corporation
18.3.5. CYTOO S.A.
18.3.6. Eligo Bioscience
18.3.7. EnBiotix Inc.
18.3.8. Fixed-Phage Limited
18.3.9. Intralytix Inc.
18.3.10. iNtRON Biotechnology
18.3.11. Locus Biosciences Inc.
18.3.12. Micreos BV
18.3.13. Optipharm Co. Ltd.
18.3.14. Phage International Inc.
18.3.15. Phagelux Inc.
18.3.16. Phagomed Biopharma GmbH
18.3.17. Pherecydes Pharma
18.3.18. Phico Therapeutics Ltd.
18.3.19. Sexton Biotechnologies
18.3.20. TechnoPhage SA
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BACTERIOPHAGE MARKET MULTI-CURRENCY
FIGURE 2. BACTERIOPHAGE MARKET MULTI-LANGUAGE
FIGURE 3. BACTERIOPHAGE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BACTERIOPHAGE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BACTERIOPHAGE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. BACTERIOPHAGE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. BACTERIOPHAGE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BACTERIOPHAGE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BACTERIOPHAGE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BACTERIOPHAGE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FILAMENTOUS PHAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TEMPERATE PHAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYTIC PHAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FISH PATHOGEN CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BACTERIOPHAGE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BACTERIOPHAGE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BACTERIOPHAGE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BACTERIOPHAGE MARKET SIZE, BY SELF-MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BACTERIOPHAGE MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TOPICAL SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BACTERIOPHAGE MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BACTERIOPHAGE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ENTEROBACTERIACEAE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PSEUDOMONADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BACTERIOPHAGE MARKET SIZE, BY GRAM-POSITIVE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 92. CANADA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. CANADA BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 94. CANADA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 96. CANADA BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 97. CANADA BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 98. CANADA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 99. CANADA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. CANADA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. CANADA BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 102. CANADA BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 103. CANADA BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. CANADA BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 105. CANADA BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 164. CHINA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. CHINA BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 166. CHINA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. CHINA BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 168. CHINA BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 169. CHINA BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 170. CHINA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 171. CHINA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. CHINA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. CHINA BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 174. CHINA BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 175. CHINA BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. CHINA BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 177. CHINA BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 178. INDIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. INDIA BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 180. INDIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. INDIA BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 182. INDIA BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 183. INDIA BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 184. INDIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 185. INDIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. INDIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. INDIA BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 188. INDIA BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 189. INDIA BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. INDIA BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 191. INDIA BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 206. JAPAN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. JAPAN BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 208. JAPAN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. JAPAN BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 210. JAPAN BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 211. JAPAN BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 212. JAPAN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 213. JAPAN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. JAPAN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. JAPAN BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 216. JAPAN BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 217. JAPAN BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. JAPAN BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 219. JAPAN BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 230. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 231. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 233. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 244. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 245. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 258. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 283. TAIWAN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. TAIWAN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. TAIWAN BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 286. TAIWAN BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 287. TAIWAN BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 288. TAIWAN BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 289. TAIWAN BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 290. THAILAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 291. THAILAND BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 292. THAILAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. THAILAND BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 294. THAILAND BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 295. THAILAND BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 296. THAILAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 297. THAILAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. THAILAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. THAILAND BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 300. THAILAND BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 301. THAILAND BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 302. THAILAND BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 303. THAILAND BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 304. VIETNAM BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 305. VIETNAM BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 306. VIETNAM BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. VIETNAM BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 308. VIETNAM BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 333. DENMARK BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 334. DENMARK BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 335. DENMARK BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. DENMARK BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 337. DENMARK BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 338. DENMARK BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 339. DENMARK BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 340. DENMARK BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 341. DENMARK BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 342. DENMARK BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 343. DENMARK BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 344. DENMARK BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 345. DENMARK BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 346. DENMARK BACTERIOPHAGE MARKET SIZE, BY GRAM-NEGATIVE INFECTIONS, 2018-2030 (USD MILLION)
TABLE 347. EGYPT BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 348. EGYPT BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC PHAGES, 2018-2030 (USD MILLION)
TABLE 349. EGYPT BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 350. EGYPT BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 351. EGYPT BACTERIOPHAGE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 352. EGYPT BACTERIOPHAGE MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 353. EGYPT BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 354. EGYPT BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 355. EGYPT BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 356. EGYPT BACTERIOPHAGE MARKET SIZE, BY BACTERIOPHAGE PREPARATION, 2018-2030 (USD MILLION)
TABLE 357. EGYPT BACTERIOPHAGE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 358. EGYPT BACTERIOPHAGE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 359. EGYPT BACTERIOPHAGE MARKET SIZE, BY TARGET BACTERIA, 2018-2030 (USD MILLION)
TABLE 360. EGYPT BACTERIOPHAGE MAR

Companies Mentioned

  • Adaptive Phage Therapeutics
  • AmpliPhi Biosciences Corporation
  • Armata Pharmaceuticals Inc.
  • ContraFect Corporation
  • CYTOO S.A.
  • Eligo Bioscience
  • EnBiotix Inc.
  • Fixed-Phage Limited
  • Intralytix Inc.
  • iNtRON Biotechnology
  • Locus Biosciences Inc.
  • Micreos BV
  • Optipharm Co. Ltd.
  • Phage International Inc.
  • Phagelux Inc.
  • Phagomed Biopharma GmbH
  • Pherecydes Pharma
  • Phico Therapeutics Ltd.
  • Sexton Biotechnologies
  • TechnoPhage SA

Methodology

Loading
LOADING...

Related Topics

Related Reports

Bacteriophage Therapy - Global Strategic Business Report - Product Image

Bacteriophage Therapy - Global Strategic Business Report

  • Report
  • 494 Pages
  • Global
From
Biochemistry, International Adaptation. Edition No. 4 - Product Image

Biochemistry, International Adaptation. Edition No. 4

  • Book
  • 1488 Pages
  • Global
Biosensors. Nanomaterials, Approaches, and Performance-Enhancement Strategies. Edition No. 1. IEEE Press Series on Sensors - Product Image

Biosensors. Nanomaterials, Approaches, and Performance-Enhancement Strategies. Edition No. 1. IEEE Press Series on Sensors

  • Book
  • 336 Pages
Current Developments in Biotechnology and Bioengineering. Environmental and Health Impact of Hospital Wastewater - Product Image

Current Developments in Biotechnology and Bioengineering. Environmental and Health Impact of Hospital Wastewater

  • Book
Laboratory Practices in Microbiology - Product Image

Laboratory Practices in Microbiology

  • Book

About the Bacteriophage Market

Bacteriophages, also known as phages, are viruses that infect and replicate within bacteria. They are of great interest to the biotechnology industry due to their potential to be used as therapeutic agents against bacterial infections. Phage therapy has been used for decades in Eastern Europe and is now gaining traction in the West as an alternative to antibiotics. Phage therapy is being explored for a variety of applications, including the treatment of antibiotic-resistant infections, the prevention of biofilm formation, and the delivery of therapeutic proteins. Companies are developing phage-based products for a range of indications, including wound healing, skin care, and food safety. The bacteriophage market is expected to grow significantly in the coming years as more companies enter the space and develop new products. Companies in the market include AmpliPhi Biosciences, Intralytix, Adaptive Phage Therapeutics, and Phagelux. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.